<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38146118</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-3038</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title><ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation></Journal><ArticleTitle>Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC).</ArticleTitle><Pagination><StartPage>e14060</StartPage><MedlinePgn>e14060</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.14060</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A proportion of the convalescent SARS-CoV-2 pediatric population presents nonspecific symptoms, mental health problems, and a reduction in quality of life similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID-19 symptomatic. However, data regarding its clinical manifestation and immune mechanisms are currently scarce.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we perform a comprehensive clinical and immunological profiling of 17 convalescent COVID-19 children with post-acute COVID-19 sequelae (PASC) manifestation and 13 convalescent children without PASC manifestation. A detailed medical history, blood and instrumental tests, and physical examination were obtained from all patients. SARS-CoV-2 reactive T-cell response was analyzed via multiparametric flow cytometry and the humoral immunity was addressed via pseudovirus neutralization and ELISA assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The most common PASC symptoms were shortness of breath/exercise intolerance, paresthesia, smell/taste disturbance, chest pain, dyspnea, headache, and lack of concentration. Blood count and clinical chemistry showed no statistical differences among the study groups. We detected higher frequencies of spike (S) reactive CD4<sup>+</sup> and CD8<sup>+</sup> T cells among the PASC study group, characterized by TNF&#x3b1; and IFN&#x3b3; production and low functional avidity. CRP levels are positively correlated with IFN&#x3b3; producing reactive CD8<sup>+</sup> T cells.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data might indicate a possible involvement of a persistent cellular inflammatory response triggered by SARS-CoV-2 in the development of the observed sequelae in pediatric PASC. These results may have implications on future therapeutic and prevention strategies.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paniskaki</LastName><ForeName>Krystallenia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6226-7558</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goretzki</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anft</LastName><ForeName>Moritz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konik</LastName><ForeName>Margarethe J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meister</LastName><ForeName>Toni L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaender</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lechtenberg</LastName><ForeName>Klara</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogl</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics III, Pediatric Pulmonology and Sleep Medicine, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>Burcin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolff</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westhoff</LastName><ForeName>Timm H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohn</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felderhoff-Mueser</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Neuro- and Behavioral Sciences C-TNBS, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stervbo</LastName><ForeName>Ulrik</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzke</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dohna-Schwake</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics I, Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Neuro- and Behavioral Sciences C-TNBS, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babel</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - University Clinic Berlin, BIH Center for Regenerative Therapies (BCRT) Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Allergy Immunol</MedlineTA><NlmUniqueID>9106718</NlmUniqueID><ISSNLinking>0905-6157</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neutralizing antibodies</Keyword><Keyword MajorTopicYN="N">pediatric PASC</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>0</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38146118</ArticleId><ArticleId IdType="doi">10.1111/pai.14060</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Fainardi V, Meoli A, Chiopris G, et&#xa0;al. Long COVID in children and adolescents. Life. 2022;12(2):285. doi:10.3390/life12020285</Citation></Reference><Reference><Citation>Mehta NS, Mytton OT, Mullins EWS, et&#xa0;al. SARS-CoV-2 (COVID-19): what do we know about children? A systematic review. Clin Infect Dis. 2020;71:2469-2479. doi:10.1093/cid/ciaa556</Citation></Reference><Reference><Citation>Fialkowski A, Gernez Y, Arya P, Weinacht KG, Kinane TB, Yonker LM. Insight into the pediatric and adult dichotomy of COVID-19: age-related differences in the immune response to SARS-CoV-2 infection. Pediatr Pulmonol. 2020;55(10):2556-2564. doi:10.1002/ppul.24981</Citation></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et&#xa0;al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968-981.e7. doi:10.1016/j.cell.2020.09.016</Citation></Reference><Reference><Citation>Bogunovic D, Merad M. Children and SARS-CoV-2. Cell Host Microbe. 2021;29:1040-1042. doi:10.1016/j.chom.2021.06.015</Citation></Reference><Reference><Citation>Sorg AL, Becht S, Jank M, et&#xa0;al. Association of SARS-CoV-2 seropositivity with myalgic encephalomyelitis and/or chronic fatigue syndrome among children and adolescents in Germany. JAMA Netw Open. 2022;5(9):e2233454. doi:10.1001/jamanetworkopen.2022.33454</Citation></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597-1607. doi:10.1007/s00431-021-04345-z</Citation></Reference><Reference><Citation>Leftin Dobkin SC, Collaco JM, McGrath-Morrow SA. Protracted respiratory findings in children post-SARS-CoV-2 infection. Pediatr Pulmonol. 2021;56(12):3682-3687. doi:10.1002/ppul.25671</Citation></Reference><Reference><Citation>Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. 2022;59(2):2102245. doi:10.1183/13993003.02245-2021</Citation></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, et&#xa0;al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000-1009. doi:10.1001/jamapediatrics.2022.2800</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, et&#xa0;al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi:10.1038/s41598-022-13495-5</Citation></Reference><Reference><Citation>Kikkenborg Berg S, Palm P, Nygaard U, et&#xa0;al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14&#x2009;years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. 2022;6(9):614-623. doi:10.1016/S2352-4642(22)00154-7</Citation></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et&#xa0;al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi:10.1136/bmjgh-2021-005427</Citation></Reference><Reference><Citation>Funk AL, Kuppermann N, Florin TA, et&#xa0;al. Post-COVID-19 conditions among children 90&#x2009;days after sars-cov-2 infection. JAMA Netw Open. 2022;5(7):e2223253. doi:10.1001/jamanetworkopen.2022.23253</Citation></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et&#xa0;al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-895.e20. doi:10.1016/j.cell.2022.01.014</Citation></Reference><Reference><Citation>Grandjean L, Saso A, Torres Ortiz A, et&#xa0;al. Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2. Clin Infect Dis. 2022;74(7):1220-1229. doi:10.1093/cid/ciab607</Citation></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911-923. doi:10.1038/s41591-022-01810-6</Citation></Reference><Reference><Citation>Koczulla A, Ankermann T, Behrends U, et&#xa0;al. S1-Leitlinie Post-COVID/Long-COVID. Pneumologie. 2021;75(11):869-900. doi:10.1055/a-1551-9734</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi:10.1016/S2213-2600(21)00031-X</Citation></Reference><Reference><Citation>Brasseler M, Sch&#xf6;necker A, Steindor M, et&#xa0;al. Development of restrictive eating disorders in children and adolescents with long-COVID-associated smell and taste dysfunction. Front Pediatr. 2022;10:1022669. doi:10.3389/fped.2022.1022669</Citation></Reference><Reference><Citation>Thieme CJ, Anft M, Paniskaki K, et&#xa0;al. Robust T cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients. Cell Rep Med. 2020;1(6):100092. doi:10.1016/j.xcrm.2020.100092</Citation></Reference><Reference><Citation>Paniskaki K, Anft M, Meister TL, et&#xa0;al. Immune response in moderate to critical breakthrough COVID-19 infection after mRNA vaccination. Front Immunol. 2022;13:816220. doi:10.3389/fimmu.2022.816220</Citation></Reference><Reference><Citation>Anft M, Paniskaki K, Blazquez-Navarro A, et&#xa0;al. COVID-19-induced ARDS is associated with decreased frequency of activated memory/effector T cells expressing CD11a++. Mol Ther. 2020;28(12):2691-2702. doi:10.1016/j.ymthe.2020.10.001</Citation></Reference><Reference><Citation>Bacher P, Rosati E, Esser D, et&#xa0;al. Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity. 2020;53(6):1258-1271.e5. doi:10.1016/j.immuni.2020.11.016</Citation></Reference><Reference><Citation>Loyal L, Braun J, Henze L, et&#xa0;al. Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021;374:eabh1823. doi:10.1126/science.abh1823</Citation></Reference><Reference><Citation>Paniskaki K, Konik MJ, Anft M, et&#xa0;al. Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination. Front Immunol. 2022;13:1031254. doi:10.3389/fimmu.2022.1031254</Citation></Reference><Reference><Citation>Kent SJ, Khoury DS, Reynaldi A, et&#xa0;al. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast? Nat Rev Immunol. 2022;22(6):387-397. doi:10.1038/s41577-022-00716-1</Citation></Reference><Reference><Citation>Finlay JB, Brann DH, Abi Hachem R, et&#xa0;al. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci Transl Med. 2022;14:eadd0484. doi:10.1126/scitranslmed.add0484</Citation></Reference><Reference><Citation>Cheon IS, Li C, Son YM, et&#xa0;al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6:eabk1741. doi:10.1126/sciimmunol.abk1741</Citation></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et&#xa0;al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210-216. doi:10.1038/s41590-021-01113-x</Citation></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, et&#xa0;al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18(5):e1010359. doi:10.1371/journal.ppat.1010359</Citation></Reference><Reference><Citation>Lanzer KG, Cookenham T, Reiley WW, Blackman MA. Virtual memory cells make a major contribution to the response of aged influenza-na&#xef;ve mice to influenza virus infection. Immun Ageing. 2018;15:17. doi:10.1186/s12979-018-0122-y</Citation></Reference><Reference><Citation>Wynberg E, Han AX, Boyd A, et&#xa0;al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40(32):4424-4431. doi:10.1016/j.vaccine.2022.05.090</Citation></Reference><Reference><Citation>Deuel JW, Lauria E, Lovey T, et&#xa0;al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the swiss armed forces: a longitudinal, cohort study (LoCoMo). Lancet Infect Dis. 2022;22(12):1694-1702. doi:10.1016/S1473-3099(22)00449-2</Citation></Reference><Reference><Citation>Paniskaki K, Konik MJ, Anft M, et&#xa0;al. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19. Front Microbiol. 2023;14:1196721. doi:10.3389/fmicb.2023.1196721</Citation></Reference><Reference><Citation>Durazo FA, Nicholas AA, Mahaffey JJ, et&#xa0;al. Post-Covid-19 cholangiopathy-a new indication for liver transplantation: a case report. Transplant Proc. 2021;53:1132-1137. doi:10.1016/j.transproceed.2021.03.007</Citation></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, et&#xa0;al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077-1082. doi:10.14309/ajg.0000000000001154</Citation></Reference><Reference><Citation>Cooper S, Tobar A, Konen O, et&#xa0;al. Long COVID-19 liver manifestation in children. J Pediatr Gastroenterol Nutr. 2022;75(3):244-251. doi:10.1097/MPG.0000000000003521</Citation></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, et&#xa0;al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis. 2022;225(12):2155-2162. doi:10.1093/infdis/jiac017</Citation></Reference><Reference><Citation>Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. 2019;10:1696. doi:10.3389/fimmu.2019.01696</Citation></Reference><Reference><Citation>Klimas NG, Broderick G, Fletcher MA. Biomarkers for chronic fatigue. Brain Behav Immun. 2012;26(8):1202-1210. doi:10.1016/j.bbi.2012.06.006</Citation></Reference><Reference><Citation>Raison CL, Lin JMS, Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun. 2009;23(3):327-337. doi:10.1016/j.bbi.2008.11.005</Citation></Reference><Reference><Citation>Pedraz-Petrozzi B, Neumann E, Sammer G. Pro-inflammatory markers and fatigue in patients with depression: a case-control study. Sci Rep. 2020;10(1):9494. doi:10.1038/s41598-020-66532-6</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, et&#xa0;al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185(14):2452-2468.e16. doi:10.1016/j.cell.2022.06.008</Citation></Reference><Reference><Citation>Etter MM, Martins TA, Kulsvehagen L, et&#xa0;al. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun. 2022;13(1):6777. doi:10.1038/s41467-022-34068-0</Citation></Reference><Reference><Citation>Kiho S, Rameen J, Abhiroop C, et&#xa0;al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61(1):2200970. doi:10.1183/13993003.00970-2022</Citation></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, et&#xa0;al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879-882. doi:10.1038/s41591-022-01766-7</Citation></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, et&#xa0;al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76(3):e487-e490. doi:10.1093/cid/ciac722</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>